Latest Auditing News

Jatcorp’s Q1 FY27 revenue fell 52.4% to A$4.66 million as a sharper seasonal downturn in China hit brand sales and OEM orders. Cash fell to A$3.727 million after A$2.145 million of operating outflows, leaving the company’s reported funding estimate at 1.7 quarters.

Singular Health has moved closer to a proposed A$3.5 million Florida Medicaid imaging repository while deploying 1,000 physician licences through its largest customer network. The September quarter also exposed the execution risks ahead, with the Florida MOU still subject to definitive agreements and the PNS contract due for renewal by year-end.

Hydrix reported stronger contract momentum and launched a defence strategy in FY26, but revenue fell, cash burn increased and its statutory loss widened to $6.72 million. The auditor identified a material uncertainty over the company’s ability to continue as a going concern, despite a $5.2 million capital raising and planned debt conversions.

Saunders International says it expects revenue growth and sustained second-half margin improvement in FY27 after reporting record FY26 revenue of A$305.6 million. Its opportunity pipeline reached A$5.1 billion, although converting that pipeline into profitable work remains the central test.

IVE Group’s FY26 revenue slipped 1.8%, but stronger margins lifted underlying pre-AASB 16 NPAT by 3.0% to A$52.5 million and supported a higher final dividend. The marketing and communications group expects underlying pre-AASB 16 profit to be broadly stable in FY27 as new capacity and acquisitions begin to contribute.

The Star Entertainment returned to positive quarterly EBITDA in Q1 FY27, with Sydney and Gold Coast revenue recording year-on-year growth for the first time since quarterly reporting began. The improvement comes alongside negative reported operating cash flow, continuing casino licence restrictions and unresolved going-concern uncertainties.

NeuroScientific Biopharmaceuticals has secured favourable US FDA feedback on its planned StemSmart Phase 2 trial for refractory Crohn’s disease, while appointing a clinical research partner and advancing manufacturing validation. The company enters the next phase with $3.91 million in cash and a targeted trial start by the end of 2026.

Queste Communications is seeking shareholder approval to leave the ASX, arguing that limited trading, concentrated ownership and listing costs no longer justify its quoted status. If approved and accepted by ASX, trading could end on 29 December 2026, leaving shareholders to sell privately after delisting.

Orion Equities will ask shareholders to approve a voluntary ASX delisting, arguing that sparse trading, concentrated ownership and annual listing costs no longer justify its quoted status. The move would leave shareholders relying on private transactions to sell their shares if the delisting proceeds.

GR Engineering Services delivered stronger FY26 earnings and lifted its dividend, but the scale of its new project pipeline is bringing a substantial working-capital requirement. The ASX-listed contractor is forecasting FY27 revenue of A$825 million to A$850 million after securing more than A$1 billion in contracts since April.

Bougainville Copper has asked the ASX to reinstate quotation trading after lodging its delayed half-year report, but the exchange has not yet approved a resumption. The company has acknowledged repeated reporting failures and introduced tighter internal controls.

Australian Mines has moved its Flemington scandium project into a larger pre-feasibility study while Boa Vista drilling adds a second growth track. But the FY2026 annual report also records a A$7.1 million loss, A$5.0 million in impairments and a material uncertainty over continued funding.